NovoCure's total assets for Q1 2025 were $1.25B, an increase of 0.65% from the previous quarter. NVCR total liabilities were $886.85M for the fiscal quarter, a 0.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.